EICHORPublic-registry site landscape for NCT02544061, “NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds”, a Colostomy Stoma study sponsored by Neumedicines Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02544061 (registry record) |
| Study title | NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds |
| Official title | A Phase IIa Open-label, Randomized Study to Compare the Safety, Tolerability and Pharmacokinetics (PK) of NM-IL-12 (rHuIL-12) to Standard of Care in Subjects With Open Surgical Wounds Following Colostomy Takedown |
| Sponsor | Neumedicines Inc. |
| Condition(s) | Colostomy Stoma |
| Phase | PHASE2 |
| Listed sites | 3 |
| Intervention(s) | NM-IL-12, Placebo |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT02544061.
Eichor generates a preliminary site-risk snapshot for NCT02544061 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
